Winkey Peptides have capitalised on the expiration of certain molecular patents by recreating their formulations, allowing them to provide a more competitive price than the original suppliers, with no difference in the chemical composition, quality, or concentrations.
This applies to formulations containing any of the following, either exclusively or in combination:
- Palmitoyl Tripeptide-1
- Palmitoyl Tetrapeptide-7
- Palmitoyl Pentapeptide-4
- Dipeptide-2
The peptides that these apply to can be seen below:
Winkey has also looked to the future and has already produced its versions of peptides that will be ready for purchase after the patent expiration dates have been reached.
This applies to any formulation that contains any of the following, either exclusively or in combination:
- Palmitoyl Tripeptpide-5
- Acetyl Hexapeptide-8
The peptides that these apply to can be seen below:
In addition to the peptides outlined in this e-mail, Winkey continues to develop a growing list of their own exclusive peptides, along with matches to existing molecules, ready for when original EU patents expire, going as far forward as 2032.
If you’d like to learn more about any of these peptides, have any questions regarding our wider product portfolio or would like to request pricing and a sample, please don’t hesitate to get in touch.